nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A4—alcohol dependence	0.355	1	CbGaD
Levomilnacipran—SLC6A4—Citalopram—alcohol dependence	0.115	0.288	CbGbCtD
Levomilnacipran—SLC6A2—Citalopram—alcohol dependence	0.0966	0.241	CbGbCtD
Levomilnacipran—ABCB1—Naltrexone—alcohol dependence	0.0464	0.116	CbGbCtD
Levomilnacipran—CYP2C19—Citalopram—alcohol dependence	0.0381	0.0951	CbGbCtD
Levomilnacipran—ABCB1—Citalopram—alcohol dependence	0.0307	0.0767	CbGbCtD
Levomilnacipran—CYP2D6—Citalopram—alcohol dependence	0.029	0.0723	CbGbCtD
Levomilnacipran—CYP3A4—Disulfiram—alcohol dependence	0.0258	0.0645	CbGbCtD
Levomilnacipran—CYP3A4—Citalopram—alcohol dependence	0.0184	0.046	CbGbCtD
Levomilnacipran—SLC6A2—locus ceruleus—alcohol dependence	0.0051	0.148	CbGeAlD
Levomilnacipran—SLC6A2—autonomic nervous system—alcohol dependence	0.00271	0.0788	CbGeAlD
Levomilnacipran—SLC6A2—nerve—alcohol dependence	0.00152	0.0443	CbGeAlD
Levomilnacipran—CYP2J2—forebrain—alcohol dependence	0.00133	0.0387	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—alcohol dependence	0.0012	0.226	CrCbGaD
Levomilnacipran—CYP2J2—cardiovascular system—alcohol dependence	0.00112	0.0327	CbGeAlD
Levomilnacipran—Pethidine—OPRK1—alcohol dependence	0.00104	0.197	CrCbGaD
Levomilnacipran—Diethylpropion—SLC6A3—alcohol dependence	0.00089	0.168	CrCbGaD
Levomilnacipran—CYP2J2—midbrain—alcohol dependence	0.000878	0.0255	CbGeAlD
Levomilnacipran—Pethidine—GRIN2B—alcohol dependence	0.000876	0.166	CrCbGaD
Levomilnacipran—Hepatitis—Disulfiram—alcohol dependence	0.000867	0.00651	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Disulfiram—alcohol dependence	0.000862	0.00648	CcSEcCtD
Levomilnacipran—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00085	0.00639	CcSEcCtD
Levomilnacipran—Blood pressure increased—Naltrexone—alcohol dependence	0.000804	0.00604	CcSEcCtD
Levomilnacipran—Galactorrhoea—Citalopram—alcohol dependence	0.000786	0.0059	CcSEcCtD
Levomilnacipran—CYP2J2—endocrine gland—alcohol dependence	0.000771	0.0224	CbGeAlD
Levomilnacipran—SLC6A4—brainstem—alcohol dependence	0.000743	0.0216	CbGeAlD
Levomilnacipran—CYP2J2—testis—alcohol dependence	0.000735	0.0214	CbGeAlD
Levomilnacipran—Suicidal ideation—Citalopram—alcohol dependence	0.000727	0.00546	CcSEcCtD
Levomilnacipran—CYP2J2—nervous system—alcohol dependence	0.000722	0.021	CbGeAlD
Levomilnacipran—SLC6A4—forebrain—alcohol dependence	0.000717	0.0208	CbGeAlD
Levomilnacipran—Mania—Citalopram—alcohol dependence	0.000701	0.00526	CcSEcCtD
Levomilnacipran—CYP2J2—liver—alcohol dependence	0.000695	0.0202	CbGeAlD
Levomilnacipran—CYP2J2—central nervous system—alcohol dependence	0.000695	0.0202	CbGeAlD
Levomilnacipran—CYP2J2—cerebellum—alcohol dependence	0.000679	0.0198	CbGeAlD
Levomilnacipran—Extrapyramidal disorder—Citalopram—alcohol dependence	0.000677	0.00508	CcSEcCtD
Levomilnacipran—Renal failure acute—Acamprosate—alcohol dependence	0.000668	0.00502	CcSEcCtD
Levomilnacipran—Libido decreased—Acamprosate—alcohol dependence	0.000665	0.005	CcSEcCtD
Levomilnacipran—SLC6A2—brainstem—alcohol dependence	0.000654	0.019	CbGeAlD
Levomilnacipran—Thirst—Acamprosate—alcohol dependence	0.000648	0.00487	CcSEcCtD
Levomilnacipran—SLC6A2—forebrain—alcohol dependence	0.000631	0.0184	CbGeAlD
Levomilnacipran—Libido decreased—Naltrexone—alcohol dependence	0.00063	0.00473	CcSEcCtD
Levomilnacipran—Hot flush—Naltrexone—alcohol dependence	0.000624	0.00469	CcSEcCtD
Levomilnacipran—Hyponatraemia—Acamprosate—alcohol dependence	0.00062	0.00465	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Naltrexone—alcohol dependence	0.000619	0.00465	CcSEcCtD
Levomilnacipran—Endocrine disorder—Citalopram—alcohol dependence	0.000615	0.00462	CcSEcCtD
Levomilnacipran—Thirst—Naltrexone—alcohol dependence	0.000614	0.00461	CcSEcCtD
Levomilnacipran—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.000612	0.0046	CcSEcCtD
Levomilnacipran—Migraine—Acamprosate—alcohol dependence	0.000607	0.00456	CcSEcCtD
Levomilnacipran—Delirium—Citalopram—alcohol dependence	0.000593	0.00445	CcSEcCtD
Levomilnacipran—Contusion—Citalopram—alcohol dependence	0.000584	0.00439	CcSEcCtD
Levomilnacipran—Aggression—Citalopram—alcohol dependence	0.00058	0.00436	CcSEcCtD
Levomilnacipran—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.000579	0.00435	CcSEcCtD
Levomilnacipran—Chest discomfort—Citalopram—alcohol dependence	0.000576	0.00433	CcSEcCtD
Levomilnacipran—Rhabdomyolysis—Citalopram—alcohol dependence	0.000576	0.00433	CcSEcCtD
Levomilnacipran—Migraine—Naltrexone—alcohol dependence	0.000575	0.00432	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Acamprosate—alcohol dependence	0.00057	0.00428	CcSEcCtD
Levomilnacipran—Dry skin—Acamprosate—alcohol dependence	0.000566	0.00425	CcSEcCtD
Levomilnacipran—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.000564	0.00424	CcSEcCtD
Levomilnacipran—Pethidine—OPRM1—alcohol dependence	0.000562	0.106	CrCbGaD
Levomilnacipran—Breast disorder—Acamprosate—alcohol dependence	0.000558	0.00419	CcSEcCtD
Levomilnacipran—Irritability—Naltrexone—alcohol dependence	0.000557	0.00419	CcSEcCtD
Levomilnacipran—Paraesthesia—Disulfiram—alcohol dependence	0.000553	0.00415	CcSEcCtD
Levomilnacipran—CYP2J2—brain—alcohol dependence	0.000552	0.016	CbGeAlD
Levomilnacipran—Somnolence—Disulfiram—alcohol dependence	0.000547	0.00411	CcSEcCtD
Levomilnacipran—Hypercholesterolaemia—Citalopram—alcohol dependence	0.000539	0.00405	CcSEcCtD
Levomilnacipran—Abdominal distension—Acamprosate—alcohol dependence	0.000537	0.00403	CcSEcCtD
Levomilnacipran—Fatigue—Disulfiram—alcohol dependence	0.000531	0.00399	CcSEcCtD
Levomilnacipran—Angina pectoris—Acamprosate—alcohol dependence	0.00052	0.0039	CcSEcCtD
Levomilnacipran—Blood pressure increased—Citalopram—alcohol dependence	0.00051	0.00383	CcSEcCtD
Levomilnacipran—SLC6A4—digestive system—alcohol dependence	0.000503	0.0146	CbGeAlD
Levomilnacipran—Cystitis noninfective—Citalopram—alcohol dependence	0.000498	0.00374	CcSEcCtD
Levomilnacipran—Pollakiuria—Acamprosate—alcohol dependence	0.000493	0.0037	CcSEcCtD
Levomilnacipran—Cystitis—Citalopram—alcohol dependence	0.000492	0.0037	CcSEcCtD
Levomilnacipran—Angina pectoris—Naltrexone—alcohol dependence	0.000492	0.00369	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Acamprosate—alcohol dependence	0.000491	0.00369	CcSEcCtD
Levomilnacipran—SLC6A2—gonad—alcohol dependence	0.000484	0.0141	CbGeAlD
Levomilnacipran—Weight decreased—Acamprosate—alcohol dependence	0.000483	0.00362	CcSEcCtD
Levomilnacipran—SLC6A4—blood—alcohol dependence	0.000479	0.0139	CbGeAlD
Levomilnacipran—SLC6A4—midbrain—alcohol dependence	0.000473	0.0138	CbGeAlD
Levomilnacipran—Dry eye—Citalopram—alcohol dependence	0.000471	0.00354	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.000469	0.00352	CcSEcCtD
Levomilnacipran—Urinary tract infection—Acamprosate—alcohol dependence	0.000462	0.00347	CcSEcCtD
Levomilnacipran—Bladder pain—Citalopram—alcohol dependence	0.000461	0.00346	CcSEcCtD
Levomilnacipran—Weight decreased—Naltrexone—alcohol dependence	0.000457	0.00343	CcSEcCtD
Levomilnacipran—Haematuria—Acamprosate—alcohol dependence	0.000453	0.00341	CcSEcCtD
Levomilnacipran—Asthenia—Disulfiram—alcohol dependence	0.000442	0.00332	CcSEcCtD
Levomilnacipran—Urinary tract infection—Naltrexone—alcohol dependence	0.000437	0.00329	CcSEcCtD
Levomilnacipran—Hepatitis—Acamprosate—alcohol dependence	0.000427	0.00321	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Naltrexone—alcohol dependence	0.000426	0.0032	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Acamprosate—alcohol dependence	0.000425	0.00319	CcSEcCtD
Levomilnacipran—Hallucination—Acamprosate—alcohol dependence	0.000425	0.00319	CcSEcCtD
Levomilnacipran—Oedema peripheral—Acamprosate—alcohol dependence	0.000421	0.00316	CcSEcCtD
Levomilnacipran—CYP2C19—digestive system—alcohol dependence	0.000417	0.0121	CbGeAlD
Levomilnacipran—SLC6A4—endocrine gland—alcohol dependence	0.000416	0.0121	CbGeAlD
Levomilnacipran—Pethidine—SLC6A3—alcohol dependence	0.000414	0.0783	CrCbGaD
Levomilnacipran—Dizziness—Disulfiram—alcohol dependence	0.000407	0.00306	CcSEcCtD
Levomilnacipran—Hepatitis—Naltrexone—alcohol dependence	0.000404	0.00303	CcSEcCtD
Levomilnacipran—Hallucination—Naltrexone—alcohol dependence	0.000402	0.00302	CcSEcCtD
Levomilnacipran—Renal failure acute—Citalopram—alcohol dependence	0.000401	0.00301	CcSEcCtD
Levomilnacipran—Libido decreased—Citalopram—alcohol dependence	0.000399	0.003	CcSEcCtD
Levomilnacipran—CYP2C19—blood—alcohol dependence	0.000397	0.0116	CbGeAlD
Levomilnacipran—Connective tissue disorder—Naltrexone—alcohol dependence	0.000397	0.00298	CcSEcCtD
Levomilnacipran—Hot flush—Citalopram—alcohol dependence	0.000395	0.00297	CcSEcCtD
Levomilnacipran—Menopausal symptoms—Citalopram—alcohol dependence	0.000392	0.00294	CcSEcCtD
Levomilnacipran—SLC6A4—nervous system—alcohol dependence	0.000389	0.0113	CbGeAlD
Levomilnacipran—Thirst—Citalopram—alcohol dependence	0.000389	0.00292	CcSEcCtD
Levomilnacipran—Rash—Disulfiram—alcohol dependence	0.000388	0.00292	CcSEcCtD
Levomilnacipran—Headache—Disulfiram—alcohol dependence	0.000386	0.0029	CcSEcCtD
Levomilnacipran—Chills—Acamprosate—alcohol dependence	0.000383	0.00288	CcSEcCtD
Levomilnacipran—Eye disorder—Naltrexone—alcohol dependence	0.000377	0.00284	CcSEcCtD
Levomilnacipran—Cardiac disorder—Naltrexone—alcohol dependence	0.000375	0.00282	CcSEcCtD
Levomilnacipran—SLC6A4—central nervous system—alcohol dependence	0.000375	0.0109	CbGeAlD
Levomilnacipran—Mental disorder—Acamprosate—alcohol dependence	0.000374	0.00281	CcSEcCtD
Levomilnacipran—Malnutrition—Acamprosate—alcohol dependence	0.000372	0.00279	CcSEcCtD
Levomilnacipran—Hyponatraemia—Citalopram—alcohol dependence	0.000371	0.00279	CcSEcCtD
Levomilnacipran—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000367	0.00276	CcSEcCtD
Levomilnacipran—Angiopathy—Naltrexone—alcohol dependence	0.000366	0.00275	CcSEcCtD
Levomilnacipran—Flatulence—Acamprosate—alcohol dependence	0.000366	0.00275	CcSEcCtD
Levomilnacipran—SLC6A2—endocrine gland—alcohol dependence	0.000366	0.0106	CbGeAlD
Levomilnacipran—Tension—Acamprosate—alcohol dependence	0.000365	0.00274	CcSEcCtD
Levomilnacipran—Migraine—Citalopram—alcohol dependence	0.000364	0.00274	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Naltrexone—alcohol dependence	0.000364	0.00273	CcSEcCtD
Levomilnacipran—Dysgeusia—Acamprosate—alcohol dependence	0.000364	0.00273	CcSEcCtD
Levomilnacipran—Chills—Naltrexone—alcohol dependence	0.000362	0.00272	CcSEcCtD
Levomilnacipran—CYP2D6—brainstem—alcohol dependence	0.000358	0.0104	CbGeAlD
Levomilnacipran—Mental disorder—Naltrexone—alcohol dependence	0.000354	0.00266	CcSEcCtD
Levomilnacipran—Irritability—Citalopram—alcohol dependence	0.000353	0.00265	CcSEcCtD
Levomilnacipran—Urinary retention—Citalopram—alcohol dependence	0.000352	0.00264	CcSEcCtD
Levomilnacipran—Malnutrition—Naltrexone—alcohol dependence	0.000352	0.00264	CcSEcCtD
Levomilnacipran—SLC6A2—testis—alcohol dependence	0.000349	0.0102	CbGeAlD
Levomilnacipran—Tremor—Acamprosate—alcohol dependence	0.000348	0.00262	CcSEcCtD
Levomilnacipran—CYP2C8—blood—alcohol dependence	0.000347	0.0101	CbGeAlD
Levomilnacipran—Flatulence—Naltrexone—alcohol dependence	0.000346	0.0026	CcSEcCtD
Levomilnacipran—CYP2D6—forebrain—alcohol dependence	0.000345	0.0101	CbGeAlD
Levomilnacipran—Tension—Naltrexone—alcohol dependence	0.000345	0.00259	CcSEcCtD
Levomilnacipran—CYP2C19—endocrine gland—alcohol dependence	0.000344	0.01	CbGeAlD
Levomilnacipran—Dysgeusia—Naltrexone—alcohol dependence	0.000344	0.00259	CcSEcCtD
Levomilnacipran—SLC6A2—nervous system—alcohol dependence	0.000343	0.00996	CbGeAlD
Levomilnacipran—Liver function test abnormal—Citalopram—alcohol dependence	0.000342	0.00257	CcSEcCtD
Levomilnacipran—Agitation—Acamprosate—alcohol dependence	0.000342	0.00257	CcSEcCtD
Levomilnacipran—Dry skin—Citalopram—alcohol dependence	0.000339	0.00255	CcSEcCtD
Levomilnacipran—Breast disorder—Citalopram—alcohol dependence	0.000334	0.00251	CcSEcCtD
Levomilnacipran—Syncope—Acamprosate—alcohol dependence	0.000333	0.0025	CcSEcCtD
Levomilnacipran—Leukopenia—Acamprosate—alcohol dependence	0.000333	0.0025	CcSEcCtD
Levomilnacipran—Vision blurred—Naltrexone—alcohol dependence	0.000331	0.00249	CcSEcCtD
Levomilnacipran—SLC6A2—central nervous system—alcohol dependence	0.00033	0.00959	CbGeAlD
Levomilnacipran—Tremor—Naltrexone—alcohol dependence	0.000329	0.00247	CcSEcCtD
Levomilnacipran—Palpitations—Acamprosate—alcohol dependence	0.000328	0.00247	CcSEcCtD
Levomilnacipran—Loss of consciousness—Acamprosate—alcohol dependence	0.000327	0.00245	CcSEcCtD
Levomilnacipran—Agitation—Naltrexone—alcohol dependence	0.000323	0.00243	CcSEcCtD
Levomilnacipran—SLC6A2—NRF2 pathway—ADH7—alcohol dependence	0.000323	0.00451	CbGpPWpGaD
Levomilnacipran—Convulsion—Acamprosate—alcohol dependence	0.000322	0.00242	CcSEcCtD
Levomilnacipran—Abdominal distension—Citalopram—alcohol dependence	0.000322	0.00242	CcSEcCtD
Levomilnacipran—Hypertension—Acamprosate—alcohol dependence	0.000321	0.00241	CcSEcCtD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.000317	0.00443	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000317	0.00443	CbGpPWpGaD
Levomilnacipran—Chest pain—Acamprosate—alcohol dependence	0.000316	0.00238	CcSEcCtD
Levomilnacipran—Syncope—Naltrexone—alcohol dependence	0.000315	0.00237	CcSEcCtD
Levomilnacipran—Anxiety—Acamprosate—alcohol dependence	0.000315	0.00237	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000314	0.00236	CcSEcCtD
Levomilnacipran—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000312	0.00436	CbGpPWpGaD
Levomilnacipran—Angina pectoris—Citalopram—alcohol dependence	0.000311	0.00234	CcSEcCtD
Levomilnacipran—Palpitations—Naltrexone—alcohol dependence	0.000311	0.00233	CcSEcCtD
Levomilnacipran—CYP2C19—liver—alcohol dependence	0.000311	0.00903	CbGeAlD
Levomilnacipran—Pethidine—SLC6A4—alcohol dependence	0.00031	0.0585	CrCbGaD
Levomilnacipran—SLC6A2—NRF2 pathway—GGT2—alcohol dependence	0.000309	0.00433	CbGpPWpGaD
Levomilnacipran—Dry mouth—Acamprosate—alcohol dependence	0.000309	0.00232	CcSEcCtD
Levomilnacipran—Loss of consciousness—Naltrexone—alcohol dependence	0.000309	0.00232	CcSEcCtD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000306	0.00428	CbGpPWpGaD
Levomilnacipran—Convulsion—Naltrexone—alcohol dependence	0.000305	0.00229	CcSEcCtD
Levomilnacipran—Hypertension—Naltrexone—alcohol dependence	0.000304	0.00228	CcSEcCtD
Levomilnacipran—Infection—Acamprosate—alcohol dependence	0.000301	0.00226	CcSEcCtD
Levomilnacipran—CYP2C8—endocrine gland—alcohol dependence	0.000301	0.00875	CbGeAlD
Levomilnacipran—Chest pain—Naltrexone—alcohol dependence	0.000299	0.00225	CcSEcCtD
Levomilnacipran—Dysuria—Citalopram—alcohol dependence	0.000299	0.00225	CcSEcCtD
Levomilnacipran—Shock—Acamprosate—alcohol dependence	0.000298	0.00224	CcSEcCtD
Levomilnacipran—Anxiety—Naltrexone—alcohol dependence	0.000298	0.00224	CcSEcCtD
Levomilnacipran—SLC6A4—brain—alcohol dependence	0.000297	0.00865	CbGeAlD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000297	0.00223	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000297	0.00223	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Acamprosate—alcohol dependence	0.000297	0.00223	CcSEcCtD
Levomilnacipran—Tachycardia—Acamprosate—alcohol dependence	0.000296	0.00222	CcSEcCtD
Levomilnacipran—Pollakiuria—Citalopram—alcohol dependence	0.000295	0.00222	CcSEcCtD
Levomilnacipran—Skin disorder—Acamprosate—alcohol dependence	0.000295	0.00221	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Citalopram—alcohol dependence	0.000294	0.00221	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Acamprosate—alcohol dependence	0.000293	0.0022	CcSEcCtD
Levomilnacipran—Dry mouth—Naltrexone—alcohol dependence	0.000293	0.0022	CcSEcCtD
Levomilnacipran—Weight decreased—Citalopram—alcohol dependence	0.000289	0.00217	CcSEcCtD
Levomilnacipran—Anorexia—Acamprosate—alcohol dependence	0.000289	0.00217	CcSEcCtD
Levomilnacipran—CYP2C8—testis—alcohol dependence	0.000287	0.00834	CbGeAlD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000285	0.00399	CbGpPWpGaD
Levomilnacipran—Infection—Naltrexone—alcohol dependence	0.000285	0.00214	CcSEcCtD
Levomilnacipran—Hypotension—Acamprosate—alcohol dependence	0.000283	0.00213	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—CYP2E1—alcohol dependence	0.000283	0.00396	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000283	0.00395	CbGpPWpGaD
Levomilnacipran—Stevens-Johnson syndrome—Citalopram—alcohol dependence	0.000283	0.00212	CcSEcCtD
Levomilnacipran—Shock—Naltrexone—alcohol dependence	0.000282	0.00212	CcSEcCtD
Levomilnacipran—Nervous system disorder—Naltrexone—alcohol dependence	0.000281	0.00211	CcSEcCtD
Levomilnacipran—Tachycardia—Naltrexone—alcohol dependence	0.00028	0.0021	CcSEcCtD
Levomilnacipran—CYP2J2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000279	0.0039	CbGpPWpGaD
Levomilnacipran—Skin disorder—Naltrexone—alcohol dependence	0.000279	0.00209	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Naltrexone—alcohol dependence	0.000277	0.00208	CcSEcCtD
Levomilnacipran—Urinary tract infection—Citalopram—alcohol dependence	0.000277	0.00208	CcSEcCtD
Levomilnacipran—Insomnia—Acamprosate—alcohol dependence	0.000274	0.00206	CcSEcCtD
Levomilnacipran—Anorexia—Naltrexone—alcohol dependence	0.000274	0.00205	CcSEcCtD
Levomilnacipran—Paraesthesia—Acamprosate—alcohol dependence	0.000272	0.00205	CcSEcCtD
Levomilnacipran—Haematuria—Citalopram—alcohol dependence	0.000272	0.00204	CcSEcCtD
Levomilnacipran—CYP2C8—liver—alcohol dependence	0.000271	0.00788	CbGeAlD
Levomilnacipran—Dyspnoea—Acamprosate—alcohol dependence	0.00027	0.00203	CcSEcCtD
Levomilnacipran—Somnolence—Acamprosate—alcohol dependence	0.00027	0.00203	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Citalopram—alcohol dependence	0.00027	0.00203	CcSEcCtD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000269	0.00377	CbGpPWpGaD
Levomilnacipran—Dyspepsia—Acamprosate—alcohol dependence	0.000267	0.00201	CcSEcCtD
Levomilnacipran—Decreased appetite—Acamprosate—alcohol dependence	0.000264	0.00198	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000262	0.00197	CcSEcCtD
Levomilnacipran—SLC6A2—brain—alcohol dependence	0.000262	0.00762	CbGeAlD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00026	0.00364	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—GGT1—alcohol dependence	0.00026	0.00363	CbGpPWpGaD
Levomilnacipran—Insomnia—Naltrexone—alcohol dependence	0.00026	0.00195	CcSEcCtD
Levomilnacipran—Constipation—Acamprosate—alcohol dependence	0.000259	0.00195	CcSEcCtD
Levomilnacipran—Paraesthesia—Naltrexone—alcohol dependence	0.000258	0.00194	CcSEcCtD
Levomilnacipran—Hepatitis—Citalopram—alcohol dependence	0.000256	0.00192	CcSEcCtD
Levomilnacipran—Dyspnoea—Naltrexone—alcohol dependence	0.000256	0.00192	CcSEcCtD
Levomilnacipran—Somnolence—Naltrexone—alcohol dependence	0.000255	0.00192	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Citalopram—alcohol dependence	0.000255	0.00191	CcSEcCtD
Levomilnacipran—Hallucination—Citalopram—alcohol dependence	0.000255	0.00191	CcSEcCtD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.000254	0.00355	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000254	0.00354	CbGpPWpGaD
Levomilnacipran—Urinary tract disorder—Citalopram—alcohol dependence	0.000253	0.0019	CcSEcCtD
Levomilnacipran—Oedema peripheral—Citalopram—alcohol dependence	0.000252	0.00189	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Citalopram—alcohol dependence	0.000251	0.00189	CcSEcCtD
Levomilnacipran—Urethral disorder—Citalopram—alcohol dependence	0.000251	0.00188	CcSEcCtD
Levomilnacipran—Decreased appetite—Naltrexone—alcohol dependence	0.000249	0.00187	CcSEcCtD
Levomilnacipran—ABCB1—forebrain—alcohol dependence	0.000249	0.00723	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000248	0.00186	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000248	0.00186	CcSEcCtD
Levomilnacipran—Fatigue—Naltrexone—alcohol dependence	0.000247	0.00186	CcSEcCtD
Levomilnacipran—CYP3A4—digestive system—alcohol dependence	0.000246	0.00717	CbGeAlD
Levomilnacipran—Constipation—Naltrexone—alcohol dependence	0.000245	0.00184	CcSEcCtD
Levomilnacipran—CYP2D6—digestive system—alcohol dependence	0.000243	0.00705	CbGeAlD
Levomilnacipran—Erythema multiforme—Citalopram—alcohol dependence	0.000242	0.00182	CcSEcCtD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000241	0.00337	CbGpPWpGaD
Levomilnacipran—Urticaria—Acamprosate—alcohol dependence	0.000241	0.00181	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00024	0.00336	CbGpPWpGaD
Levomilnacipran—Abdominal pain—Acamprosate—alcohol dependence	0.00024	0.0018	CcSEcCtD
Levomilnacipran—Body temperature increased—Acamprosate—alcohol dependence	0.00024	0.0018	CcSEcCtD
Levomilnacipran—Eye disorder—Citalopram—alcohol dependence	0.000239	0.0018	CcSEcCtD
Levomilnacipran—CYP2C8—Biological oxidations—ADH6—alcohol dependence	0.000239	0.00334	CbGpPWpGaD
Levomilnacipran—Cardiac disorder—Citalopram—alcohol dependence	0.000238	0.00178	CcSEcCtD
Levomilnacipran—Flushing—Citalopram—alcohol dependence	0.000238	0.00178	CcSEcCtD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000236	0.0033	CbGpPWpGaD
Levomilnacipran—CYP3A4—blood—alcohol dependence	0.000235	0.00683	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000235	0.00176	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—MAOA—alcohol dependence	0.000233	0.00326	CbGpPWpGaD
Levomilnacipran—Angiopathy—Citalopram—alcohol dependence	0.000232	0.00174	CcSEcCtD
Levomilnacipran—CYP2D6—blood—alcohol dependence	0.000231	0.00672	CbGeAlD
Levomilnacipran—Mediastinal disorder—Citalopram—alcohol dependence	0.000231	0.00173	CcSEcCtD
Levomilnacipran—ABCB1—adrenal cortex—alcohol dependence	0.00023	0.0067	CbGeAlD
Levomilnacipran—Chills—Citalopram—alcohol dependence	0.00023	0.00172	CcSEcCtD
Levomilnacipran—Urticaria—Naltrexone—alcohol dependence	0.000228	0.00171	CcSEcCtD
Levomilnacipran—Abdominal pain—Naltrexone—alcohol dependence	0.000227	0.0017	CcSEcCtD
Levomilnacipran—Body temperature increased—Naltrexone—alcohol dependence	0.000227	0.0017	CcSEcCtD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000225	0.00315	CbGpPWpGaD
Levomilnacipran—Mental disorder—Citalopram—alcohol dependence	0.000224	0.00168	CcSEcCtD
Levomilnacipran—Hypersensitivity—Acamprosate—alcohol dependence	0.000223	0.00168	CcSEcCtD
Levomilnacipran—Malnutrition—Citalopram—alcohol dependence	0.000223	0.00167	CcSEcCtD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000221	0.00309	CbGpPWpGaD
Levomilnacipran—Flatulence—Citalopram—alcohol dependence	0.00022	0.00165	CcSEcCtD
Levomilnacipran—Tension—Citalopram—alcohol dependence	0.000219	0.00164	CcSEcCtD
Levomilnacipran—Dysgeusia—Citalopram—alcohol dependence	0.000218	0.00164	CcSEcCtD
Levomilnacipran—Asthenia—Acamprosate—alcohol dependence	0.000218	0.00163	CcSEcCtD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000216	0.00301	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—alcohol dependence	0.000215	0.00301	CbGpPWpGaD
Levomilnacipran—CYP2C8—brain—alcohol dependence	0.000215	0.00626	CbGeAlD
Levomilnacipran—Pruritus—Acamprosate—alcohol dependence	0.000215	0.00161	CcSEcCtD
Levomilnacipran—CYP2C19—Biological oxidations—ADH6—alcohol dependence	0.000213	0.00298	CbGpPWpGaD
Levomilnacipran—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000212	0.00297	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Naltrexone—alcohol dependence	0.000211	0.00159	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000211	0.00295	CbGpPWpGaD
Levomilnacipran—ABCB1—cardiovascular system—alcohol dependence	0.00021	0.00611	CbGeAlD
Levomilnacipran—Vision blurred—Citalopram—alcohol dependence	0.00021	0.00158	CcSEcCtD
Levomilnacipran—Tremor—Citalopram—alcohol dependence	0.000209	0.00157	CcSEcCtD
Levomilnacipran—Diarrhoea—Acamprosate—alcohol dependence	0.000208	0.00156	CcSEcCtD
Levomilnacipran—Asthenia—Naltrexone—alcohol dependence	0.000206	0.00155	CcSEcCtD
Levomilnacipran—Agitation—Citalopram—alcohol dependence	0.000205	0.00154	CcSEcCtD
Levomilnacipran—ABCB1—pancreas—alcohol dependence	0.000204	0.00594	CbGeAlD
Levomilnacipran—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000204	0.00285	CbGpPWpGaD
Levomilnacipran—CYP3A4—endocrine gland—alcohol dependence	0.000204	0.00592	CbGeAlD
Levomilnacipran—Pruritus—Naltrexone—alcohol dependence	0.000203	0.00152	CcSEcCtD
Levomilnacipran—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000203	0.00284	CbGpPWpGaD
Levomilnacipran—Dizziness—Acamprosate—alcohol dependence	0.000201	0.00151	CcSEcCtD
Levomilnacipran—CYP2D6—endocrine gland—alcohol dependence	0.0002	0.00583	CbGeAlD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0002	0.0028	CbGpPWpGaD
Levomilnacipran—Syncope—Citalopram—alcohol dependence	0.0002	0.0015	CcSEcCtD
Levomilnacipran—Leukopenia—Citalopram—alcohol dependence	0.000199	0.0015	CcSEcCtD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000198	0.00277	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH1A—alcohol dependence	0.000198	0.00277	CbGpPWpGaD
Levomilnacipran—Palpitations—Citalopram—alcohol dependence	0.000197	0.00148	CcSEcCtD
Levomilnacipran—Diarrhoea—Naltrexone—alcohol dependence	0.000196	0.00147	CcSEcCtD
Levomilnacipran—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000196	0.00274	CbGpPWpGaD
Levomilnacipran—Loss of consciousness—Citalopram—alcohol dependence	0.000196	0.00147	CcSEcCtD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000196	0.00274	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000194	0.00271	CbGpPWpGaD
Levomilnacipran—Convulsion—Citalopram—alcohol dependence	0.000193	0.00145	CcSEcCtD
Levomilnacipran—Vomiting—Acamprosate—alcohol dependence	0.000193	0.00145	CcSEcCtD
Levomilnacipran—Hypertension—Citalopram—alcohol dependence	0.000192	0.00144	CcSEcCtD
Levomilnacipran—Rash—Acamprosate—alcohol dependence	0.000191	0.00144	CcSEcCtD
Levomilnacipran—CYP2D6—testis—alcohol dependence	0.000191	0.00556	CbGeAlD
Levomilnacipran—Dermatitis—Acamprosate—alcohol dependence	0.000191	0.00144	CcSEcCtD
Levomilnacipran—ABCB1—gonad—alcohol dependence	0.000191	0.00555	CbGeAlD
Levomilnacipran—CYP3A4—nervous system—alcohol dependence	0.000191	0.00554	CbGeAlD
Levomilnacipran—Headache—Acamprosate—alcohol dependence	0.00019	0.00143	CcSEcCtD
Levomilnacipran—Dizziness—Naltrexone—alcohol dependence	0.00019	0.00143	CcSEcCtD
Levomilnacipran—Chest pain—Citalopram—alcohol dependence	0.00019	0.00142	CcSEcCtD
Levomilnacipran—Anxiety—Citalopram—alcohol dependence	0.000189	0.00142	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000188	0.00141	CcSEcCtD
Levomilnacipran—CYP2D6—nervous system—alcohol dependence	0.000188	0.00546	CbGeAlD
Levomilnacipran—Dry mouth—Citalopram—alcohol dependence	0.000186	0.00139	CcSEcCtD
Levomilnacipran—CYP3A4—liver—alcohol dependence	0.000184	0.00534	CbGeAlD
Levomilnacipran—CYP3A4—central nervous system—alcohol dependence	0.000184	0.00534	CbGeAlD
Levomilnacipran—Vomiting—Naltrexone—alcohol dependence	0.000182	0.00137	CcSEcCtD
Levomilnacipran—Rash—Naltrexone—alcohol dependence	0.000181	0.00136	CcSEcCtD
Levomilnacipran—Dermatitis—Naltrexone—alcohol dependence	0.000181	0.00136	CcSEcCtD
Levomilnacipran—CYP2D6—liver—alcohol dependence	0.000181	0.00526	CbGeAlD
Levomilnacipran—SLC6A4—NRF2 pathway—SLC6A3—alcohol dependence	0.000181	0.00253	CbGpPWpGaD
Levomilnacipran—Infection—Citalopram—alcohol dependence	0.000181	0.00136	CcSEcCtD
Levomilnacipran—CYP2D6—central nervous system—alcohol dependence	0.000181	0.00525	CbGeAlD
Levomilnacipran—Nausea—Acamprosate—alcohol dependence	0.00018	0.00135	CcSEcCtD
Levomilnacipran—Headache—Naltrexone—alcohol dependence	0.00018	0.00135	CcSEcCtD
Levomilnacipran—Shock—Citalopram—alcohol dependence	0.000179	0.00134	CcSEcCtD
Levomilnacipran—Nervous system disorder—Citalopram—alcohol dependence	0.000178	0.00134	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Citalopram—alcohol dependence	0.000178	0.00134	CcSEcCtD
Levomilnacipran—Tachycardia—Citalopram—alcohol dependence	0.000177	0.00133	CcSEcCtD
Levomilnacipran—CYP2C19—Biological oxidations—ADH1A—alcohol dependence	0.000177	0.00247	CbGpPWpGaD
Levomilnacipran—Skin disorder—Citalopram—alcohol dependence	0.000177	0.00133	CcSEcCtD
Levomilnacipran—CYP2D6—cerebellum—alcohol dependence	0.000176	0.00513	CbGeAlD
Levomilnacipran—Hyperhidrosis—Citalopram—alcohol dependence	0.000176	0.00132	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000175	0.00244	CbGpPWpGaD
Levomilnacipran—ABCB1—digestive system—alcohol dependence	0.000174	0.00507	CbGeAlD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000174	0.00244	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC6A4—alcohol dependence	0.000174	0.00244	CbGpPWpGaD
Levomilnacipran—Anorexia—Citalopram—alcohol dependence	0.000173	0.0013	CcSEcCtD
Levomilnacipran—Nausea—Naltrexone—alcohol dependence	0.00017	0.00128	CcSEcCtD
Levomilnacipran—SLC6A4—NRF2 pathway—GGT1—alcohol dependence	0.00017	0.00238	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00017	0.00238	CbGpPWpGaD
Levomilnacipran—Hypotension—Citalopram—alcohol dependence	0.00017	0.00128	CcSEcCtD
Levomilnacipran—SLC6A4—Circadian rythm related genes—CRH—alcohol dependence	0.000169	0.00236	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH4—alcohol dependence	0.000168	0.00235	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000166	0.00233	CbGpPWpGaD
Levomilnacipran—ABCB1—blood—alcohol dependence	0.000166	0.00483	CbGeAlD
Levomilnacipran—Insomnia—Citalopram—alcohol dependence	0.000164	0.00124	CcSEcCtD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000164	0.00229	CbGpPWpGaD
Levomilnacipran—ABCB1—midbrain—alcohol dependence	0.000164	0.00477	CbGeAlD
Levomilnacipran—CYP2J2—Metabolism—ADH6—alcohol dependence	0.000164	0.00229	CbGpPWpGaD
Levomilnacipran—Paraesthesia—Citalopram—alcohol dependence	0.000163	0.00123	CcSEcCtD
Levomilnacipran—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.000162	0.00227	CbGpPWpGaD
Levomilnacipran—Dyspnoea—Citalopram—alcohol dependence	0.000162	0.00122	CcSEcCtD
Levomilnacipran—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000162	0.00226	CbGpPWpGaD
Levomilnacipran—Somnolence—Citalopram—alcohol dependence	0.000162	0.00121	CcSEcCtD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000161	0.00225	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00016	0.00224	CbGpPWpGaD
Levomilnacipran—Dyspepsia—Citalopram—alcohol dependence	0.00016	0.0012	CcSEcCtD
Levomilnacipran—Decreased appetite—Citalopram—alcohol dependence	0.000158	0.00119	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000157	0.00118	CcSEcCtD
Levomilnacipran—Fatigue—Citalopram—alcohol dependence	0.000157	0.00118	CcSEcCtD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000156	0.00218	CbGpPWpGaD
Levomilnacipran—Constipation—Citalopram—alcohol dependence	0.000155	0.00117	CcSEcCtD
Levomilnacipran—SLC6A2—NRF2 pathway—SLC6A3—alcohol dependence	0.000155	0.00217	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—POMC—alcohol dependence	0.000152	0.00212	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH4—alcohol dependence	0.00015	0.0021	CbGpPWpGaD
Levomilnacipran—Gastrointestinal pain—Citalopram—alcohol dependence	0.000149	0.00112	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000149	0.00208	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD4—alcohol dependence	0.000148	0.00206	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000146	0.00205	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—GGT1—alcohol dependence	0.000146	0.00205	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000145	0.00202	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000145	0.00202	CbGpPWpGaD
Levomilnacipran—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000145	0.00202	CbGpPWpGaD
Levomilnacipran—Urticaria—Citalopram—alcohol dependence	0.000144	0.00108	CcSEcCtD
Levomilnacipran—ABCB1—endocrine gland—alcohol dependence	0.000144	0.00419	CbGeAlD
Levomilnacipran—Abdominal pain—Citalopram—alcohol dependence	0.000144	0.00108	CcSEcCtD
Levomilnacipran—Body temperature increased—Citalopram—alcohol dependence	0.000144	0.00108	CcSEcCtD
Levomilnacipran—CYP2D6—brain—alcohol dependence	0.000143	0.00417	CbGeAlD
Levomilnacipran—CYP2C8—Biological oxidations—ADH7—alcohol dependence	0.000143	0.002	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000142	0.00198	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000139	0.00194	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000138	0.00193	CbGpPWpGaD
Levomilnacipran—ABCB1—testis—alcohol dependence	0.000137	0.004	CbGeAlD
Levomilnacipran—SLC6A4—Circadian rythm related genes—HTR7—alcohol dependence	0.000137	0.00192	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—DRD2—alcohol dependence	0.000137	0.00192	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GGT2—alcohol dependence	0.000137	0.00192	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000137	0.00191	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000136	0.00191	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH1A—alcohol dependence	0.000136	0.0019	CbGpPWpGaD
Levomilnacipran—ABCB1—nervous system—alcohol dependence	0.000135	0.00392	CbGeAlD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000135	0.00188	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Citalopram—alcohol dependence	0.000134	0.00101	CcSEcCtD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000133	0.00186	CbGpPWpGaD
Levomilnacipran—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000133	0.00186	CbGpPWpGaD
Levomilnacipran—Asthenia—Citalopram—alcohol dependence	0.00013	0.00098	CcSEcCtD
Levomilnacipran—ABCB1—liver—alcohol dependence	0.00013	0.00378	CbGeAlD
Levomilnacipran—ABCB1—central nervous system—alcohol dependence	0.00013	0.00378	CbGeAlD
Levomilnacipran—Pruritus—Citalopram—alcohol dependence	0.000129	0.000966	CcSEcCtD
Levomilnacipran—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000128	0.00179	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH7—alcohol dependence	0.000128	0.00179	CbGpPWpGaD
Levomilnacipran—ABCB1—cerebellum—alcohol dependence	0.000127	0.00369	CbGeAlD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000127	0.00177	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ADH1B—alcohol dependence	0.000125	0.00175	CbGpPWpGaD
Levomilnacipran—Diarrhoea—Citalopram—alcohol dependence	0.000124	0.000934	CcSEcCtD
Levomilnacipran—CYP2C19—Biological oxidations—GGT2—alcohol dependence	0.000122	0.00171	CbGpPWpGaD
Levomilnacipran—Dizziness—Citalopram—alcohol dependence	0.00012	0.000903	CcSEcCtD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000119	0.00166	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000118	0.00165	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000117	0.00164	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—AVP—alcohol dependence	0.000116	0.00162	CbGpPWpGaD
Levomilnacipran—Vomiting—Citalopram—alcohol dependence	0.000116	0.000868	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism—ADH4—alcohol dependence	0.000115	0.00161	CbGpPWpGaD
Levomilnacipran—Rash—Citalopram—alcohol dependence	0.000115	0.000861	CcSEcCtD
Levomilnacipran—Dermatitis—Citalopram—alcohol dependence	0.000115	0.00086	CcSEcCtD
Levomilnacipran—Headache—Citalopram—alcohol dependence	0.000114	0.000856	CcSEcCtD
Levomilnacipran—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000113	0.00157	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ADH1B—alcohol dependence	0.000112	0.00157	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000109	0.00153	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000109	0.00153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000109	0.00152	CbGpPWpGaD
Levomilnacipran—Nausea—Citalopram—alcohol dependence	0.000108	0.000811	CcSEcCtD
Levomilnacipran—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000106	0.00148	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000105	0.00147	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—MAOB—alcohol dependence	0.000104	0.00145	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000103	0.00144	CbGpPWpGaD
Levomilnacipran—ABCB1—brain—alcohol dependence	0.000103	0.003	CbGeAlD
Levomilnacipran—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000103	0.00144	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	9.98e-05	0.0014	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH7—alcohol dependence	9.8e-05	0.00137	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	9.79e-05	0.00137	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	9.77e-05	0.00137	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GGT2—alcohol dependence	9.4e-05	0.00131	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—MAOB—alcohol dependence	9.28e-05	0.0013	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH4—alcohol dependence	9.03e-05	0.00126	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	8.99e-05	0.00126	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	8.93e-05	0.00125	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—ALDH2—alcohol dependence	8.84e-05	0.00124	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	8.81e-05	0.00123	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	8.79e-05	0.00123	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	8.79e-05	0.00123	CbGpPWpGaD
Levomilnacipran—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	8.69e-05	0.00122	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ADH1B—alcohol dependence	8.6e-05	0.0012	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—MAOB—alcohol dependence	8.54e-05	0.00119	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—AVP—alcohol dependence	8.1e-05	0.00113	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—ALDH2—alcohol dependence	7.89e-05	0.0011	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	7.85e-05	0.0011	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH7—alcohol dependence	7.68e-05	0.00107	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GGT2—alcohol dependence	7.36e-05	0.00103	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	7.26e-05	0.00101	CbGpPWpGaD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	7.22e-05	0.00101	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	7.14e-05	0.000998	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	7.13e-05	0.000996	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MAOB—alcohol dependence	7.12e-05	0.000996	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CYP2E1—alcohol dependence	7.07e-05	0.000988	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metapathway biotransformation—CYP2E1—alcohol dependence	6.97e-05	0.000974	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	6.73e-05	0.000941	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GGT1—alcohol dependence	6.49e-05	0.000907	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	6.36e-05	0.000889	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	6.31e-05	0.000882	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	6.25e-05	0.000873	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	6.22e-05	0.00087	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALDH2—alcohol dependence	6.06e-05	0.000847	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	5.88e-05	0.000821	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	5.85e-05	0.000818	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.82e-05	0.000814	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—MAOA—alcohol dependence	5.81e-05	0.000813	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	5.8e-05	0.000811	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GGT1—alcohol dependence	5.79e-05	0.00081	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	5.72e-05	0.0008	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—MAOB—alcohol dependence	5.58e-05	0.00078	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GGT1—alcohol dependence	5.33e-05	0.000745	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—MAOA—alcohol dependence	5.19e-05	0.000725	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT2—alcohol dependence	5.15e-05	0.00072	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	5.1e-05	0.000713	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	4.98e-05	0.000695	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP2E1—alcohol dependence	4.84e-05	0.000677	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—MAOA—alcohol dependence	4.77e-05	0.000667	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	4.75e-05	0.000663	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	4.72e-05	0.00066	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	4.71e-05	0.000658	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	4.55e-05	0.000636	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT1—alcohol dependence	4.45e-05	0.000621	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GGT1—alcohol dependence	4.45e-05	0.000621	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—AVP—alcohol dependence	4.12e-05	0.000575	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH6—alcohol dependence	4.08e-05	0.000571	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MAOA—alcohol dependence	3.98e-05	0.000557	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	3.87e-05	0.000541	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.86e-05	0.00054	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	3.83e-05	0.000535	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	3.79e-05	0.00053	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—alcohol dependence	3.79e-05	0.000529	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	3.74e-05	0.000523	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH6—alcohol dependence	3.65e-05	0.00051	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH6—alcohol dependence	3.56e-05	0.000497	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GGT1—alcohol dependence	3.48e-05	0.000487	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH1A—alcohol dependence	3.38e-05	0.000473	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—alcohol dependence	3.38e-05	0.000472	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH6—alcohol dependence	3.35e-05	0.000469	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—MAOA—alcohol dependence	3.12e-05	0.000436	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—alcohol dependence	3.11e-05	0.000434	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH1A—alcohol dependence	3.02e-05	0.000422	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH1A—alcohol dependence	2.95e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH4—alcohol dependence	2.88e-05	0.000402	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH1A—alcohol dependence	2.78e-05	0.000388	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—alcohol dependence	2.59e-05	0.000362	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH4—alcohol dependence	2.57e-05	0.000359	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH4—alcohol dependence	2.51e-05	0.00035	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.49e-05	0.000348	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH7—alcohol dependence	2.45e-05	0.000342	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH4—alcohol dependence	2.36e-05	0.00033	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT2—alcohol dependence	2.35e-05	0.000328	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	2.22e-05	0.000311	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH6—alcohol dependence	2.19e-05	0.000306	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	2.19e-05	0.000306	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH7—alcohol dependence	2.18e-05	0.000305	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ADH1B—alcohol dependence	2.15e-05	0.0003	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH7—alcohol dependence	2.13e-05	0.000298	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT2—alcohol dependence	2.09e-05	0.000293	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT2—alcohol dependence	2.04e-05	0.000286	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—alcohol dependence	2.03e-05	0.000284	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	2.01e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH7—alcohol dependence	2.01e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT2—alcohol dependence	1.93e-05	0.000269	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ADH1B—alcohol dependence	1.92e-05	0.000268	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ADH1B—alcohol dependence	1.87e-05	0.000261	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH1A—alcohol dependence	1.82e-05	0.000254	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	1.81e-05	0.000253	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MAOB—alcohol dependence	1.78e-05	0.000249	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ADH1B—alcohol dependence	1.76e-05	0.000246	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—EP300—alcohol dependence	1.72e-05	0.00024	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MAOB—alcohol dependence	1.59e-05	0.000222	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MAOB—alcohol dependence	1.55e-05	0.000217	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH4—alcohol dependence	1.54e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH2—alcohol dependence	1.51e-05	0.000211	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MAOB—alcohol dependence	1.46e-05	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.45e-05	0.000203	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH2—alcohol dependence	1.35e-05	0.000189	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH2—alcohol dependence	1.32e-05	0.000184	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH7—alcohol dependence	1.31e-05	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	1.3e-05	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT2—alcohol dependence	1.29e-05	0.00018	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT2—alcohol dependence	1.26e-05	0.000176	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH2—alcohol dependence	1.24e-05	0.000173	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2E1—alcohol dependence	1.21e-05	0.000169	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ADH1B—alcohol dependence	1.15e-05	0.000161	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—alcohol dependence	1.15e-05	0.00016	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—alcohol dependence	1.12e-05	0.000157	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—alcohol dependence	1.11e-05	0.000155	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—alcohol dependence	1.11e-05	0.000155	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2E1—alcohol dependence	1.08e-05	0.000151	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—alcohol dependence	1.06e-05	0.000148	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2E1—alcohol dependence	1.05e-05	0.000147	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MAOA—alcohol dependence	9.94e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2E1—alcohol dependence	9.92e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—alcohol dependence	9.9e-06	0.000138	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—alcohol dependence	9.9e-06	0.000138	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—alcohol dependence	9.67e-06	0.000135	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—alcohol dependence	9.67e-06	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	9.64e-06	0.000135	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MAOB—alcohol dependence	9.54e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—alcohol dependence	9.11e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—alcohol dependence	9.11e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MAOA—alcohol dependence	8.88e-06	0.000124	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MAOA—alcohol dependence	8.66e-06	0.000121	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	8.61e-06	0.00012	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MAOA—alcohol dependence	8.16e-06	0.000114	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH2—alcohol dependence	8.11e-06	0.000113	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—alcohol dependence	6.9e-06	9.64e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2E1—alcohol dependence	6.49e-06	9.07e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—alcohol dependence	6.47e-06	9.05e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—alcohol dependence	5.96e-06	8.33e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—alcohol dependence	5.96e-06	8.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—alcohol dependence	5.78e-06	8.08e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—alcohol dependence	5.64e-06	7.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MAOA—alcohol dependence	5.34e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—alcohol dependence	5.32e-06	7.43e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—EP300—alcohol dependence	4.29e-06	6e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—EP300—alcohol dependence	3.83e-06	5.36e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—EP300—alcohol dependence	3.74e-06	5.23e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—EP300—alcohol dependence	3.53e-06	4.93e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—alcohol dependence	3.48e-06	4.86e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—EP300—alcohol dependence	2.31e-06	3.22e-05	CbGpPWpGaD
